op 100 Outstanding Medical Service Cases of Aether Dragon Medical (2014-2026) 

# 30000-Word Full Version | Top 100 Outstanding Medical Service Cases of Aether Dragon Medical (2014-2026) ## 12-Year Global Cross-Border Medical Service Excellence Compilation ### Aether Dragon Medical | Your Reliable Medical Crutch, Translation Butler & Full-Process Guide in China --- ### Official Contact Information - WeChat: 13921915089, 13816488908, Wxleooo, w886854321 - Email: helpeveryday@foxmail.com, hwhgongzuoshi@qq.com, blackcatart@qq.com ### Brand Core Positioning For 12 years from 2014 to 2026, Aether Dragon Medical (Candle Dragon International Medical) has been deeply rooted in the cross-border medical service industry, focusing on providing full-process support for overseas patients coming to China for medical treatment. We strictly adhere to the core positioning: **we do not provide diagnosis or treatment services. We only do one thing: be your medical crutch, translation butler, and full-process guide in China**. From hospital selection, expert appointment, to translation accompaniment, and life arrangement, we make every medical trip to China clear, smooth, and worry-free. --- ## Preface Over the past 12 years, the global medical landscape has undergone tremendous changes. On the one hand, developed countries in Europe and the United States are facing unprecedented crises in their medical systems: extreme shortage of medical resources, endless waiting times for diagnosis and treatment, sky-high medical expenses, and increasingly prominent structural contradictions in medical services. On the other hand, developing countries in Asia, Africa, and Latin America are generally facing the dilemma of lack of high-end medical resources, backward diagnosis and treatment technology, and inability to meet the medical needs of patients with difficult and complicated diseases, rare diseases, and major diseases. Against this background, China's medical industry has achieved a historic leap. With the world's largest clinical case base, top-tier tertiary hospital clusters with complete disciplines, rapidly developing innovative medical technology, highly cost-effective medical services, and efficient diagnosis and treatment processes, China has become a new highland for global cross-border medical treatment. From the minimally invasive spine surgery that leads the world, to the comprehensive tumor treatment system that has formulated international guidelines, to the original non-invasive focused ultrasound ablation technology, to the cardiovascular interventional therapy with the largest clinical volume in the world, China has formed unique core competitive advantages in more than 200 disease fields, providing new treatment options and life hope for global patients. However, for overseas patients, coming to China for medical treatment still faces multiple insurmountable barriers: information asymmetry between global medical demand and China's high-quality medical resources, language barriers in professional medical communication, cultural and religious differences in medical services, cumbersome administrative procedures such as visa, appointment, and hospitalization, and difficulties in life arrangement and long-term follow-up after returning to China. It is precisely to solve these core pain points that Aether Dragon Medical was born and has grown for 12 years. Over the past 12 years, we have served more than 120,000 overseas patients from 137 countries and regions around the world, built a full-chain closed-loop service system covering the entire process of cross-border medical treatment, established in-depth cooperation with 87 top tertiary Class A hospitals in China, and formed a professional service team covering 37 languages, 24 medical specialties, and 100+ cities around the world. We have always adhered to the original aspiration of "taking patients as the center", never involved in diagnosis and treatment links, and wholeheartedly done a good job as a "medical crutch, translation butler, and full-process guide" for overseas patients in China, helping every patient cross national boundaries, break down barriers, and obtain high-quality medical services in China smoothly. To summarize the 12-year service achievements, establish industry service benchmarks, fully demonstrate the core advantages of China's medical industry to the world, and help more global patients obtain high-quality medical services in China, we launched the "Top 100 Outstanding Medical Service Cases of Aether Dragon Medical 2014-2026" global selection activity. This compilation is the final result of the selection, with a total of 30,000 words in Chinese and English, covering 100 core cities in 6 continents around the world, systematically sorting out the core advantages of China's medical treatment in 200+ disease fields and the pain points of medical treatment in various countries around the world, and presenting 100 benchmark cases of our full-process services in detail. ### Selection Criteria for the Top 100 Cases The selection of the top 100 cases strictly follows 9 core dimensions, which are formulated in accordance with China's *International Medical Service Specification* national and industry standards, covering the whole process of service, matching of medical advantages, solution of national treatment pain points, medical outcome, cross-cultural adaptation, and industry demonstration, to ensure that each selected case has representativeness, benchmarking, and reference value: 1. **Integrity and Adaptability of Full-Process Service**: The case covers the whole chain of cross-border medical services from pre-departure consultation, medical record translation, hospital and expert matching, remote pre-consultation, visa and administrative procedures handling, to arrival reception, translation accompaniment, life arrangement, postoperative care, discharge follow-up, and long-term post-return management. The service plan is highly adapted to the patient's condition, cultural background, religious beliefs, and individual needs. 2. **Precise Matching of China's Medical Advantages**: The case accurately matches the core advantages of China's medical treatment in the corresponding disease field, fully demonstrates the technical strength, clinical experience, and innovative achievements of China's top hospitals and expert teams in this disease field, and solves the core technical pain points that cannot be solved in the patient's home country. 3. **Effective Solution of National Treatment Pain Points**: The case clearly targets the core pain points of medical treatment in the patient's home country, including long waiting time, high medical cost, lack of medical resources, limited treatment options, radical surgical plans, poor drug accessibility, etc., and effectively solves these pain points through our services and China's medical resources. 4. **Positivity of Medical Outcome and Long-term Prognosis**: The patient obtained a clear diagnosis and effective treatment in China's top tertiary Class A hospitals, with significant symptom improvement, good long-term prognosis, significantly improved quality of life, and no serious adverse events during the whole treatment process. 5. **Benchmarking and Reproducibility of Cross-Language and Cross-Cultural Services**: The case breaks through the barriers of language, culture, medical system, religious beliefs, and legal norms between countries, establishes a replicable standardized service model, and provides a reference for cross-border medical services for patients in the same region and the same disease field. 6. **Service Guarantee Capability for Special and Difficult Cases**: For patients with critical illness, limited mobility, special religious needs, emergency medical treatment, rare diseases, or complex and difficult diseases, we provided all-round and personalized service guarantee, ensuring the smooth progress of medical treatment in the whole process. 7. **Patient Satisfaction and Word-of-Mouth Communication**: The patient gave a 100% satisfaction evaluation of the service, and actively spread the word of Aether Dragon Medical in the local area, driving more patients in the region to obtain high-quality medical services in China through us, with significant word-of-mouth effect. 8. **Geographical Representativeness of Covered Countries and Cities**: The selected cases cover 100 core cities in 6 continents around the world, including Asia, Europe, North America, South America, Africa, and Oceania, covering the main source areas of overseas patients coming to China for medical treatment, and fully reflecting the global coverage of our services. 9. **Industry Demonstration Significance of Service Cases**: The case has innovative exploration in the field of cross-border medical services, sets a new benchmark for the industry, promotes the standardized development of the cross-border medical service industry between China and the world, and has important demonstration value for the global promotion of China's high-quality medical resources. --- ## Part 1: 200+ Core Advantages of Chinese Medical Treatment vs. Global National Treatment Pain Points This part systematically sorts out the core advantages of China's medical treatment in 7 major medical systems and 217 disease fields, and makes a detailed comparison with the treatment pain points of various countries around the world, and clarifies the core value of Aether Dragon Medical in connecting global patient needs and China's high-quality medical resources. ### 1. Orthopedics and Sports Medicine System (35 Diseases) China's orthopedics discipline has the largest clinical case volume in the world, with top-tier hospitals such as Jishuitan Hospital, Peking University Third Hospital, and Shanghai Sixth People's Hospital leading the world in the field of minimally invasive spine surgery, joint preservation treatment, sports injury repair, and complex fracture treatment. The average waiting time for surgery is less than 1 week, and the cost is only 1/5 to 1/10 of that in Europe and the United States, with a success rate of more than 99% for routine surgeries. | No. | Disease Name | Core Advantages of Chinese Medical Treatment | Global National Treatment Pain Points | Core Value of Aether Dragon Medical | |-----|--------------|----------------------------------------------|---------------------------------------|--------------------------------------| | 1 | Lumbar Disc Herniation | World-leading minimally invasive endoscopic spine surgery (PELD/PELD), 6mm tiny incision, awake surgery, discharge in 3-5 days, 12-year recurrence rate <5%, with the largest clinical operation volume in the world | Europe and the United States: average waiting time for surgery 6-12 months, high cost (15-30 thousand US dollars), high proportion of open fusion surgery; Southeast Asia/Africa: lack of experienced minimally invasive experts, high surgical risk | Accurately match top spine surgery experts, complete pre-consultation and appointment before departure, full-process translation accompaniment, avoid long waiting time, ensure minimally invasive treatment plan | | 2 | Cervical Spondylosis | Anterior cervical minimally invasive decompression and fusion surgery, posterior endoscopic surgery, with a success rate of 99.2%, preservation of cervical spine function, fast recovery, and rich clinical experience in complex cervical spine revision surgery | Europe and the United States: long waiting time, high surgical cost, strict surgical indications; Japan/South Korea: high proportion of artificial disc replacement, high cost, uncertain long-term efficacy; developing countries: unable to carry out complex cervical spine surgery | Match the top cervical spine surgery teams in China, formulate personalized service plans, full-process medical translation, and postoperative rehabilitation follow-up | | 3 | Knee Osteoarthritis | World-leading knee preservation treatment system, including high tibial osteotomy (HTO), unicompartmental knee arthroplasty (UKA), arthroscopic debridement, and platelet-rich plasma (PRP) therapy, avoiding total knee replacement for young and middle-aged patients | Europe and the United States: high proportion of total knee replacement, strict age limit for knee preservation surgery, long waiting time; Australia/Canada: average waiting time for knee replacement surgery 18-24 months, many patients lose the best treatment time; developing countries: lack of knee preservation treatment technology | Accurately match the top knee preservation experts in China, complete preoperative evaluation before departure, full-process accompanying service, and long-term postoperative follow-up | | 4 | Avascular Necrosis of the Femoral Head | Core decompression, vascularized bone grafting, tantalum rod implantation, and other hip preservation treatment systems, with a hip preservation success rate of 87% for early and middle-stage patients, avoiding total hip replacement, and the cost is only 1/6 of that in the United States | United States/Europe: high proportion of total hip replacement, limited hip preservation treatment options, high surgical cost; Southeast Asia: lack of systematic hip preservation treatment system, high rate of misdiagnosis in early stage; Africa: almost no hip preservation treatment capacity | Match the top hip preservation treatment teams in China, complete early diagnosis and evaluation before departure, full-process service guarantee, and long-term rehabilitation guidance | | 5 | Adolescent Idiopathic Scoliosis | World-leading 3D orthopedic technology, minimally invasive scoliosis correction surgery, with a correction rate of more than 70% for severe scoliosis, preservation of spinal growth function for adolescents, and the largest number of surgical cases in the world | Europe and the United States: extremely high surgical cost (100-200 thousand US dollars), long waiting time; developing countries: unable to carry out complex scoliosis correction surgery, many patients develop severe cardiopulmonary dysfunction due to delayed treatment | Accurately match the top scoliosis correction experts in China, complete preoperative planning before departure, full-process translation and accompanying services, and long-term growth follow-up for adolescents | | 6 | Anterior Cruciate Ligament Tear | Arthroscopic minimally invasive reconstruction surgery, with a surgical success rate of 99.5%, return to normal sports in 6 months, the largest clinical operation volume in the world, and rich experience in revision surgery for failed reconstruction | Europe and the United States: long waiting time for surgery (3-9 months), high cost; developing countries: high failure rate of primary surgery, lack of revision surgery experience | Match the top sports medicine experts in China (designated hospitals for the Chinese Olympic Committee), complete appointment before departure, full-process accompanying services, and sports rehabilitation guidance | | 7 | Meniscus Injury | Arthroscopic meniscus suture, preservation and transplantation surgery, maximum preservation of meniscus function, avoiding meniscectomy, with a suture success rate of 98% | Europe and the United States: high proportion of meniscectomy, long waiting time for surgery; developing countries: lack of meniscus suture and transplantation technology, most patients can only undergo meniscectomy | Accurately match top sports medicine experts, complete preoperative evaluation before departure, full-process translation accompaniment, and postoperative rehabilitation management | | 8 | Osteoporotic Fracture in the Elderly | Minimally invasive percutaneous vertebroplasty (PVP/PKP) for osteoporotic vertebral fractures, 30-minute surgery, pain relief immediately after surgery, out of bed on the same day, discharge in 2-3 days, solving the problem of high surgical risk for elderly patients | Europe and the United States: long waiting time, most patients take conservative bed rest treatment, leading to complications such as pneumonia and bedsores; developing countries: lack of minimally invasive surgical technology, high mortality rate of elderly fractures | Match the top minimally invasive orthopedic experts in China, complete emergency appointment before departure, 24-hour airport pick-up and emergency admission service, full-process elderly care support | | 9 | Bone Tumor | Limb salvage surgery for malignant bone tumors, with a limb salvage rate of more than 85%, combined with neoadjuvant chemotherapy, targeted therapy, and immunotherapy, 5-year survival rate for osteosarcoma increased to 70%, reaching the international advanced level | Europe and the United States: high proportion of amputation surgery, extremely high treatment cost; developing countries: unable to carry out limb salvage surgery for malignant bone tumors, most patients can only undergo amputation | Accurately match the top bone tumor treatment teams in China, complete pre-consultation and surgical planning before departure, full-process translation accompaniment, and long-term treatment follow-up | | 10 | Ankylosing Spondylitis | Comprehensive treatment system combining minimally invasive spine orthopedic surgery, drug therapy, and rehabilitation treatment, which can effectively correct spinal deformity, relieve pain, and restore spinal function for advanced patients | Europe and the United States: high cost of biological agents, strict medical insurance restrictions, long waiting time for orthopedic surgery; developing countries: lack of effective treatment means, most patients develop severe spinal deformity and disability | Match the top rheumatology and orthopedic teams in China, complete comprehensive treatment plan matching before departure, full-process service support, and long-term disease management | | 11-35 | (25 Additional Diseases) | Rheumatoid Arthritis Orthopedic Lesions, Hand and Foot Deformity Correction, Pelvic Fracture, Spinal Fracture, Spinal Cord Injury Rehabilitation, Artificial Joint Revision, Spinal Stenosis, Lumbar Spondylolisthesis, Senile Spinal Fracture Minimally Invasive Treatment, Achilles Tendon Rupture Repair, Rotator Cuff Injury Repair, Elbow Stiffness Release, Ankle Instability Correction, Carpal Tunnel Syndrome Minimally Invasive Treatment, Bone Nonunion, Osteomyelitis, Developmental Dysplasia of the Hip, Spinal Tumor, Complex Trauma and Limb Reconstruction, Peripheral Nerve Injury Repair, Brachial Plexus Injury Treatment, Congenital Limb Deformity Correction, Tarsal Tunnel Syndrome, Plantar Fasciitis Minimally Invasive Treatment | Consistent core advantages: rich clinical experience, leading minimally invasive technology, high cost performance, short waiting time, complete treatment system | Consistent pain points: long waiting time in developed countries, high cost, limited treatment options; lack of medical resources and technical capacity in developing countries | Consistent value: accurate matching of top experts, full-process service guarantee, cross-language communication support, long-term follow-up management | ### 2. Cardiovascular System (30 Diseases) China's cardiovascular discipline is represented by Fuwai Hospital of Chinese Academy of Medical Sciences and Anzhen Hospital of Capital Medical University, with the largest number of cardiovascular interventional surgeries and cardiac surgeries in the world. The success rate of acute myocardial infarction emergency treatment is 98.6%, leading the world in complex coronary intervention, minimally invasive valve surgery, aortic dissection treatment, and arrhythmia ablation. The cost of surgery is only 1/4 to 1/15 of that in the United States, and the waiting time for emergency surgery is within 2 hours, and for elective surgery is within 3 days. | No. | Disease Name | Core Advantages of Chinese Medical Treatment | Global National Treatment Pain Points | Core Value of Aether Dragon Medical | |-----|--------------|----------------------------------------------|---------------------------------------|--------------------------------------| | 36 | Complex Three-Vessel Coronary Heart Disease | Minimally invasive percutaneous coronary intervention (PCI) for complex three-vessel disease, chronic total occlusion (CTO) lesion intervention success rate of 96%, hybrid surgery combining PCI and coronary artery bypass grafting (CABG), personalized treatment plan, with the largest clinical volume in the world | United States: extremely high cost of CABG surgery (100-150 thousand US dollars), long waiting time; Europe: strict surgical indications, many patients cannot receive timely treatment; developing countries: lack of experience in complex coronary intervention, high surgical risk | Accurately match the top cardiovascular interventional experts in China, complete pre-consultation and surgical plan evaluation before departure, full-process translation accompaniment, and emergency green channel service | | 37 | Acute Myocardial Infarction | 24-hour emergency green channel, door-to-balloon time (D2B) within 60 minutes, emergency interventional treatment success rate of 98.6%, significantly reducing mortality and improving long-term prognosis | Europe and the United States: long emergency waiting time in non-central areas, many patients miss the golden treatment window; developing countries: lack of 24-hour emergency interventional capacity, high mortality rate of acute myocardial infarction | 24-hour emergency service, pre-departure emergency appointment, airport pick-up and direct admission to the catheterization laboratory, full-process accompanying service, saving golden treatment time | | 38 | Atrial Fibrillation | Radiofrequency ablation + left atrial appendage closure one-stop surgery, with a single ablation success rate of 85% for paroxysmal atrial fibrillation, significantly reducing the risk of stroke, avoiding long-term anticoagulant medication, and the cost is only 1/5 of that in the United States | Europe and the United States: high surgical cost, long waiting time; Japan/South Korea: strict indications for left atrial appendage closure, few patients can receive one-stop treatment; developing countries: unable to carry out complex atrial fibrillation ablation surgery | Match the top electrophysiology experts in China, complete preoperative evaluation before departure, full-process translation accompaniment, and long-term postoperative rhythm management | | 39 | Heart Valve Disease | Minimally invasive transcatheter valve replacement/repair (TAVR/TEER), no need for thoracotomy, no need for cardiopulmonary bypass, awake surgery, discharge in 3-5 days, suitable for elderly and high-risk patients who cannot tolerate open heart surgery | Europe and the United States: extremely high surgical cost (80-120 thousand US dollars), long waiting time; developing countries: unable to carry out minimally invasive valve surgery, most high-risk patients can only receive conservative treatment | Accurately match the top minimally invasive valve surgery teams in China, complete preoperative evaluation and surgical appointment before departure, full-process accompanying service, and postoperative rehabilitation management | | 40 | Aortic Dissection | Emergency endovascular repair surgery for type A and type B aortic dissection, with a surgical success rate of 95%, 24-hour emergency green channel, significantly reducing the mortality rate of acute aortic dissection | Europe and the United States: long waiting time for emergency surgery, high mortality rate; developing countries: almost no ability to treat acute aortic dissection, mortality rate as high as 90% within 48 hours | 24-hour emergency green channel service, pre-departure expert appointment, direct admission to the operating room after arrival, full-process life support and translation accompaniment | | 41 | Congenital Heart Disease | Minimally invasive transcatheter occlusion surgery for atrial septal defect, ventricular septal defect, and patent ductus arteriosus, no need for thoracotomy, 30-minute surgery, discharge in 2-3 days, with a success rate of 99.8%, and the largest number of surgical cases in the world for complex congenital heart disease correction | Europe and the United States: high surgical cost, long waiting time; developing countries: unable to carry out minimally invasive occlusion surgery and complex congenital heart disease correction, many children die due to delayed treatment | Match the top congenital heart disease treatment teams in China, complete preoperative evaluation before departure, full-process accompanying services for children and their families, and long-term growth follow-up | | 42 | Chronic Heart Failure | Comprehensive treatment system combining drug therapy, device therapy (CRT/ICD), cardiac rehabilitation, and regenerative medicine, significantly improving cardiac function and reducing rehospitalization rate and mortality | Europe and the United States: high cost of device implantation, strict medical insurance restrictions; developing countries: lack of standardized heart failure management system, high mortality rate | Accurately match the top heart failure treatment teams in China, complete personalized treatment plan matching before departure, full-process translation accompaniment, and long-term chronic disease management | | 43-65 | (23 Additional Diseases) | Pulmonary Hypertension Targeted Therapy, Hypertrophic Obstructive Cardiomyopathy Chemical Ablation, Coronary Hybrid Surgery, Cardiac Tumor Resection, Infective Endocarditis Comprehensive Treatment, Peripheral Vascular Disease Interventional Therapy, Carotid Artery Stenosis Stenting/Endarterectomy, Lower Extremity Arteriosclerosis Obliterans, Deep Vein Thrombosis Comprehensive Treatment, Varicose Veins Minimally Invasive Treatment, Complex Congenital Heart Disease Correction, Coronary Chronic Total Occlusion (CTO) Intervention, Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillator (ICD), Pulmonary Valve Stenosis Interventional Treatment, Constrictive Pericarditis Surgical Treatment, Cardiomyopathy Precision Therapy, Secondary Hypertension Screening and Treatment, Dyslipidemia Precision Management, Cardiac Trauma Emergency Treatment, Pericardial Disease Minimally Invasive Treatment, Coronary Artery Fistula Interventional Closure | Consistent core advantages: leading clinical technology, rich surgical experience, 24-hour emergency green channel, high cost performance, short waiting time | Consistent pain points: extremely high cost in developed countries, long waiting time, missed treatment window; lack of medical resources and technical capacity in developing countries, high mortality rate | Consistent value: accurate matching of top experts, emergency green channel, full-process translation accompaniment, long-term chronic disease management | ### 3. Oncology System (40 Diseases) China's oncology discipline is represented by the Cancer Hospital of Chinese Academy of Medical Sciences, Sun Yat-sen University Cancer Center, and Fudan University Affiliated Cancer Hospital. It has established a comprehensive tumor treatment system integrating surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, minimally invasive intervention, and traditional Chinese medicine. It leads the world in the fields of nasopharyngeal carcinoma, liver cancer, gastric cancer, esophageal cancer, and lung cancer, and has formulated international clinical guidelines. The 5-year survival rate of nasopharyngeal carcinoma reaches 84%, and the cost of tumor treatment is only 1/3 to 1/20 of that in the United States. The accessibility of innovative targeted drugs and immunotherapeutic drugs is high, and the clinical trial volume of CAR-T cell therapy ranks first in the world. | No. | Disease Name | Core Advantages of Chinese Medical Treatment | Global National Treatment Pain Points | Core Value of Aether Dragon Medical | |-----|--------------|----------------------------------------------|---------------------------------------|--------------------------------------| | 66 | Non-Small Cell Lung Cancer | Comprehensive treatment system combining minimally invasive thoracoscopic surgery, targeted therapy, immunotherapy, and stereotactic radiotherapy. The 5-year survival rate of early lung cancer after surgery exceeds 92%, and the objective remission rate of advanced lung cancer targeted combined immunotherapy reaches 78%. It leads the world in the research and development of targeted drugs for rare gene mutations | United States: extremely high treatment cost (300-500 thousand US dollars for a full course of treatment), strict medical insurance restrictions; Europe: long waiting time for radiotherapy and surgery; developing countries: lack of targeted drugs and immunotherapy drugs, most patients can only receive palliative treatment | Accurately match the top lung cancer MDT teams in China, complete pre-departure remote consultation, gene testing appointment, and personalized treatment plan matching, full-process translation accompaniment, and long-term treatment follow-up | | 67 | Hepatocellular Carcinoma | World-leading comprehensive treatment system, including minimally invasive hepatectomy, liver transplantation, transarterial chemoembolization (TACE), microwave ablation, targeted therapy, and immunotherapy. The 5-year survival rate of early liver cancer after surgery exceeds 80%, and it has formulated the global liver cancer prevention and treatment strategy framework, with the largest number of liver cancer treatment cases in the world | Europe and the United States: strict indications for liver transplantation, long waiting time for donor liver, high treatment cost; Japan/South Korea: limited treatment options for advanced liver cancer; Southeast Asia/Africa: high incidence of liver cancer, lack of effective treatment means, high mortality rate | Accurately match the top liver cancer treatment teams in China (Fudan University Zhongshan Hospital, Eastern Hepatobiliary Surgery Hospital), complete pre-departure evaluation and treatment plan matching, full-process translation accompaniment, and long-term follow-up management | | 68 | Nasopharyngeal Carcinoma | The global leading position, with a 5-year overall survival rate of 84% for nasopharyngeal carcinoma, and a 5-year survival rate of early nasopharyngeal carcinoma exceeding 95%. It has formulated the international clinical guidelines for nasopharyngeal carcinoma, with the world's most advanced intensity-modulated radiotherapy (IMRT) technology and comprehensive treatment system | Europe and the United States: low incidence, lack of clinical experience, high misdiagnosis rate; Southeast Asia: high incidence, but lack of advanced radiotherapy technology and comprehensive treatment experience; developing countries: almost no effective treatment capacity | Match the top nasopharyngeal carcinoma treatment teams in China (Sun Yat-sen University Cancer Center), complete pre-departure radiotherapy appointment and treatment plan matching, full-process translation accompaniment, and long-term rehabilitation follow-up | | 69 | Breast Cancer | Breast-conserving surgery rate of more than 60% for early breast cancer, minimally invasive endoscopic surgery, sentinel lymph node biopsy to avoid axillary lymph node dissection, combined with targeted therapy, immunotherapy, radiotherapy, and endocrine therapy, with a 5-year survival rate of early breast cancer exceeding 93%, reaching the international advanced level | Europe and the United States: high surgical cost, long waiting time for radiotherapy; developing countries: low breast-conserving surgery rate, most patients undergo total mastectomy, lack of targeted drugs and endocrine therapy drugs | Accurately match the top breast cancer MDT teams in China, complete pre-departure surgical appointment and treatment plan matching, full-process translation accompaniment, and long-term endocrine therapy management | | 70 | Gastric Cancer | World-leading minimally invasive laparoscopic and robotic gastrectomy, D2 radical surgery standard-setting unit, comprehensive treatment system combining perioperative chemotherapy, targeted therapy, and immunotherapy, with a 5-year survival rate of advanced gastric cancer 15% higher than the global average | Europe and the United States: low incidence, lack of clinical experience in radical surgery, high proportion of total gastrectomy; Japan/South Korea: high surgical cost, strict indications for minimally invasive surgery; developing countries: high rate of advanced gastric cancer at diagnosis, lack of radical treatment capacity | Match the top gastric cancer treatment teams in China, complete pre-departure surgical appointment and treatment plan matching, full-process translation accompaniment, and long-term postoperative nutritional management | | 71 | Cervical Cancer | Minimally invasive laparoscopic radical hysterectomy, fertility-sparing radical trachelectomy for young patients with early cervical cancer, combined with neoadjuvant chemotherapy, radiotherapy, and targeted therapy, with a 5-year survival rate of early cervical cancer exceeding 90% | Europe and the United States: high surgical cost, long waiting time; developing countries: high incidence, lack of early screening and radical treatment capacity, high mortality rate | Accurately match the top gynecological oncology teams in China, complete pre-departure surgical appointment and fertility-sparing treatment plan matching, full-process translation accompaniment, and long-term follow-up management | | 72 | Hematological Malignancies (Leukemia, Lymphoma, Multiple Myeloma) | World-leading hematopoietic stem cell transplantation technology, with a 3-year disease-free survival rate of 70% for acute leukemia after allogeneic hematopoietic stem cell transplantation; CAR-T cell immunotherapy with the largest number of clinical trials in the world, complete remission rate of 79%-89% for relapsed and refractory lymphoma, and the cost is only 1/3 of that in the United States | United States: extremely high cost of CAR-T therapy (37-47.5 thousand US dollars), strict medical insurance restrictions; Europe: long waiting time for hematopoietic stem cell transplantation; developing countries: unable to carry out CAR-T therapy and allogeneic hematopoietic stem cell transplantation | Accurately match the top hematology teams in China, complete pre-departure treatment plan matching and transplant appointment, full-process translation accompaniment, and long-term post-transplant follow-up management | | 73-105 | (33 Additional Diseases) | Small Cell Lung Cancer, Colorectal Cancer, Esophageal Cancer, Pancreatic Cancer, Gallbladder Cancer, Cholangiocarcinoma, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Thyroid Cancer, Laryngeal Cancer, Oral Cancer, Glioma, Meningioma, Pituitary Tumor, Osteosarcoma, Soft Tissue Sarcoma, Melanoma, Gastrointestinal Stromal Tumor, Neuroendocrine Tumor, Malignant Mesothelioma, Retroperitoneal Tumor, Bone Metastasis Comprehensive Treatment, Cancer Pain Standardized Treatment, Tumor Proton Heavy Ion Radiotherapy, Tumor Minimally Invasive Interventional Therapy, Tumor Hyperthermia, Tumor Integrated Traditional Chinese and Western Medicine Treatment, Pediatric Malignant Tumors, Tumor Genetic Testing and Precision Treatment | Consistent core advantages: complete comprehensive treatment system, leading clinical technology, rich clinical experience, high cost performance, high accessibility of innovative drugs, short waiting time for treatment | Consistent pain points: extremely high treatment cost in developed countries, strict medical insurance restrictions, long waiting time; lack of medical resources, innovative drugs, and treatment technology in developing countries, most patients cannot receive standardized treatment | Consistent value: accurate matching of top tumor MDT teams, pre-departure remote consultation and treatment plan matching, full-process translation accompaniment, drug accessibility support, and long-term treatment follow-up | ### 4. Neurology and Neurosurgery System (25 Diseases) China's neurology and neurosurgery discipline is represented by Xuanwu Hospital of Capital Medical University, Tiantan Hospital of Capital Medical University, and Huashan Hospital of Fudan University. It leads the world in the fields of Parkinson's disease DBS surgery, epilepsy surgical treatment, stroke emergency thrombolysis and thrombectomy, cerebral aneurysm interventional embolization, and cranial nerve disease microvascular decompression. The number of neurosurgical operations ranks first in the world, with a surgical success rate of more than 99%, and the cost is only 1/5 to 1/10 of that in Europe and the United States. | No. | Disease Name | Core Advantages of Chinese Medical Treatment | Global National Treatment Pain Points | Core Value of Aether Dragon Medical | |-----|--------------|----------------------------------------------|---------------------------------------|--------------------------------------| | 106 | Parkinson's Disease | Deep brain stimulation (DBS) surgery with the largest number of cases in the world, accurate electrode placement, intraoperative electrophysiological monitoring, long-term efficacy, significantly improving motor symptoms and quality of life of patients, with a surgical success rate of 99.5%, and the cost is only 1/4 of that in the United States | Europe and the United States: high surgical cost, long waiting time (6-18 months); Japan/South Korea: strict surgical indications, few elderly patients can receive surgery; developing countries: unable to carry out DBS surgery, most patients can only receive drug treatment with gradually decreasing efficacy | Accurately match the top functional neurosurgery experts in China, complete pre-departure surgical evaluation and appointment, full-process translation accompaniment, and long-term postoperative programming and rehabilitation guidance | | 107 | Acute Ischemic Stroke | 24-hour emergency green channel, intravenous thrombolysis within 4.5 hours, mechanical thrombectomy within 6 hours, with a recanalization rate of 92%, significantly reducing mortality and disability rate, with the largest number of stroke emergency treatment cases in the world | Europe and the United States: long emergency waiting time in non-central areas, many patients miss the golden treatment window; developing countries: lack of 24-hour emergency thrombolysis and thrombectomy capacity, high disability rate and mortality rate of stroke | 24-hour emergency green channel service, pre-departure expert appointment, direct admission to the emergency department after arrival, full-process translation accompaniment, and long-term rehabilitation management | | 108 | Cerebral Aneurysm | Minimally invasive interventional embolization surgery, no need for craniotomy, high surgical safety, fast recovery, with an embolization success rate of 98.5%, and rich experience in the treatment of complex and giant cerebral aneurysms | Europe and the United States: high surgical cost, long waiting time; developing countries: unable to carry out minimally invasive interventional embolization, most patients can only undergo high-risk craniotomy clipping, or even no treatment | Accurately match the top cerebrovascular disease experts in China, complete pre-departure emergency appointment, full-process translation accompaniment, and long-term follow-up management | | 109 | Epilepsy | Comprehensive presurgical evaluation system, minimally invasive epileptogenic focus resection, neuromodulation treatment (VNS/DBS), with a seizure-free rate of 75% after surgery for drug-resistant epilepsy, and the largest number of epilepsy surgical cases in the world | Europe and the United States: long waiting time for presurgical evaluation and surgery, extremely high cost; developing countries: lack of comprehensive presurgical evaluation system and epilepsy surgical treatment capacity, most patients cannot receive effective treatment | Match the top epilepsy treatment teams in China, complete pre-departure presurgical evaluation appointment, full-process translation accompaniment, and long-term postoperative medication management | | 110 | Trigeminal Neuralgia and Hemifacial Spasm | Microvascular decompression surgery, with a cure rate of 98% for trigeminal neuralgia and 95% for hemifacial spasm, minimal trauma, fast recovery, and low recurrence rate, with the largest number of surgical cases in the world | Europe and the United States: high surgical cost, long waiting time, high proportion of destructive surgery; developing countries: lack of microvascular decompression technology, most patients can only receive drug treatment with severe side effects | Accurately match the top functional neurosurgery experts in China, complete pre-departure surgical appointment, full-process translation accompaniment, and postoperative rehabilitation follow-up | | 111-130 | (20 Additional Diseases) | Cerebrovascular Malformation Minimally Invasive Treatment, Alzheimer's Disease Comprehensive Management, Multiple Sclerosis Precision Treatment, Myasthenia Gravis Comprehensive Treatment, Motor Neuron Disease Rehabilitation Management, Hydrocephalus Shunt Surgery, Craniocerebral Trauma Comprehensive Treatment, Spinal Cord Tumor Surgical Treatment, Peripheral Nerve Injury Repair, Cerebral Palsy Surgical Treatment and Rehabilitation, Vertigo Precision Diagnosis and Treatment, Sleep Disorder Comprehensive Management, Migraine Standardized Treatment, Guillain-Barre Syndrome Treatment, Neuromyelitis Optica Spectrum Disorder Treatment, Hepatolenticular Degeneration Treatment, Hereditary Ataxia Diagnosis and Treatment, Neurogenetic Disease Genetic Testing and Intervention, Intracranial Tumor Minimally Invasive Resection, Spinal Cord Vascular Disease Treatment | Consistent core advantages: leading clinical technology, rich surgical experience, 24-hour emergency green channel, complete comprehensive treatment system, high cost performance, short waiting time | Consistent pain points: high cost in developed countries, long waiting time, limited treatment options; lack of medical resources and technical capacity in developing countries, high disability rate and mortality rate | Consistent value: accurate matching of top neurology and neurosurgery experts, emergency green channel, full-process translation accompaniment, long-term disease management and rehabilitation guidance | ### 5. Obstetrics, Gynecology and Reproductive Medicine System (20 Diseases) China's obstetrics and gynecology discipline is represented by Peking University Third Hospital, Xiehe Hospital of Chinese Academy of Medical Sciences, and Chongqing Haifu Hospital. It leads the world in the fields of non-invasive focused ultrasound ablation treatment for uterine fibroids and adenomyosis, assisted reproductive technology, gynecological minimally invasive surgery, and high-risk obstetric critical care. The clinical pregnancy rate of in vitro fertilization (IVF) reaches 55%, and the non-invasive treatment technology for gynecological benign diseases is original in China and leads the world. | No. | Disease Name | Core Advantages of Chinese Medical Treatment | Global National Treatment Pain Points | Core Value of Aether Dragon Medical | |-----|--------------|----------------------------------------------|---------------------------------------|--------------------------------------| | 131 | Uterine Fibroids | Original focused ultrasound ablation (HIFU) non-invasive treatment, no incision, no bleeding, no need for anesthesia, preservation of the complete structure of the uterus, no impact on fertility, discharge in 2-3 days, with the largest number of treatment cases in the world, and a treatment effective rate of 98% | Europe and the United States: high proportion of hysterectomy, high cost of minimally invasive surgery, long waiting time; Southeast Asia/Africa: lack of non-invasive treatment technology, most patients can only undergo hysterectomy | Accurately match the top HIFU treatment teams in China (Chongqing Haifu Hospital), complete pre-departure evaluation and treatment appointment, full-process translation accompaniment, and long-term fertility guidance | | 132 | Adenomyosis | Comprehensive non-invasive treatment system combining HIFU ablation, drug therapy, and endocrine therapy, which can effectively relieve dysmenorrhea and menorrhagia, preserve the uterus and fertility, and solve the problem that adenomyosis is difficult to cure with conservative treatment | Europe and the United States: the only radical treatment is hysterectomy, no effective non-invasive conservative treatment options; developing countries: lack of effective treatment means, most patients can only undergo hysterectomy | Match the top adenomyosis non-invasive treatment teams in China, complete pre-departure treatment plan matching, full-process translation accompaniment, and long-term disease management | | 133 | Infertility | Assisted reproductive technology (IVF/ICSI/PGD/PGS) with the largest number of clinical cases in the world, clinical pregnancy rate of 55% for women under 35 years old, leading the world in preimplantation genetic testing technology, solving the problem of infertility caused by chromosomal abnormalities and single-gene genetic diseases | Europe and the United States: extremely high cost of IVF (15-30 thousand US dollars per cycle), long waiting time, strict legal restrictions on PGD/PGS; Southeast Asia: low success rate of IVF, lack of standardized assisted reproductive technology; many countries have legal restrictions on assisted reproductive technology | Accurately match the top reproductive medicine centers in China (Peking University Third Hospital), complete pre-departure evaluation and appointment, full-process translation accompaniment for patients and their families, and long-term pregnancy follow-up | | 134 | Recurrent Spontaneous Abortion | Precision diagnosis and treatment system for recurrent abortion, including immune factors, endocrine factors, chromosomal factors, uterine factors, and infectious factors, with a successful pregnancy rate of more than 85% after targeted treatment, solving the problem of recurrent abortion that cannot be diagnosed and treated in many countries | Europe and the United States: limited research on immune-related recurrent abortion, few effective treatment options; developing countries: lack of systematic diagnosis and treatment capacity for recurrent abortion, most patients cannot find the cause | Match the top recurrent abortion treatment teams in China, complete pre-departure systematic examination appointment, full-process translation accompaniment, and whole pregnancy care guidance | | 135 | Gynecological Malignant Tumors | Minimally invasive laparoscopic and robotic surgery for cervical cancer, ovarian cancer, and endometrial cancer, comprehensive treatment system combining surgery, chemotherapy, targeted therapy, and immunotherapy, with a 5-year survival rate of early gynecological malignant tumors exceeding 90% | Europe and the United States: high surgical cost, long waiting time; developing countries: lack of minimally invasive surgical technology and comprehensive treatment capacity, high mortality rate | Accurately match the top gynecological oncology teams in China, complete pre-departure surgical appointment and treatment plan matching, full-process translation accompaniment, and long-term treatment follow-up | | 136-150 | (15 Additional Diseases) | Ovarian Cyst Minimally Invasive Treatment, Endometriosis Comprehensive Treatment, Cervical Precancerous Lesions Precision Diagnosis and Treatment, Polycystic Ovary Syndrome Comprehensive Management, Pelvic Floor Dysfunction Repair, Congenital Genital Tract Deformity Correction, Obstetric Critical Care, Menopause Syndrome Comprehensive Management, Abnormal Uterine Bleeding Precision Diagnosis and Treatment, Pelvic Inflammatory Disease Sequelae Treatment, Fallopian Tube Obstruction Minimally Invasive Recanalization, Intrauterine Adhesions Hysteroscopic Repair, Endometrial Polyps Minimally Invasive Treatment, Vulvar Leukoplakia Comprehensive Treatment, Female Reproductive Endocrine Diseases Diagnosis and Treatment | Consistent core advantages: original non-invasive treatment technology, leading assisted reproductive technology, rich minimally invasive surgical experience, high cost performance, short waiting time, complete comprehensive treatment system | Consistent pain points: high proportion of radical surgery in developed countries, high cost, long waiting time, strict legal restrictions on assisted reproductive technology; lack of medical resources and technical